查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1133522

移動健康 (mHealth) 全球市場-2022-2029

Global Mobile health (mHealth) Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場動態

全球移動醫療市場的推動力在於醫療保健意識的提高、智能手機和平板電腦終端因其便利性而得到越來越多的使用，以及對個性化醫療的日益關注。

移動醫療 (mHealth) 帶來的好處和便利正在推動市場增長。

移動健康帶來的好處和便利正在推動全球市場的增長。例如，移動健康技術使患者能夠 24/7 全天候連接以快速發送安全消息、預約和接收遠程醫療。特別是，遠程醫療是患者在移動設備上使用 mHealth 應用程序增長最快的方式。它還可以通過提供使患者更有可能適當服藥的功能來提高服藥依從性，例如自動用藥和補充提醒以及教育信息。此外，遠程醫療允許患者使用移動設備和移動醫療技術來收集、輸入或自動收集健康數據並將其傳達給他們的醫療保健提供者，而遠程醫療是家庭護理的一個子類別，遠程患者護理可以實現監控。此外，M Health 提高了藥物調整的準確性，從而提高了患者的安全性。例如，Cureatr Meds 360 解決方案可讓醫療保健專業人員和其他臨床醫生在 iPhone 和 Android 屏幕上清楚地了解患者的所有處方藥的可用性、補充歷史、劑量變化等。

隱私和安全風險限制了全球移動醫療 (mHealth) 的發展。

但是，隨著黑客攻擊和數據差異的持續威脅，安全和隱私問題將在預測期內阻礙全球市場的增長。

COVID-19 影響分析

在疫情爆發期間，遠程醫療和虛擬護理受到了廣泛關注，在總有感染病毒風險的情況下，抗擊疫情變得更加方便，這對全球經濟增長產生了重大影響市場。例如，Harward 全球健康研究所創建了一個 COVID-19 預測模型，以啟用針對 COVID-19 患者、住院、ICU 入院、呼吸機使用和死亡的早期預警系統，使醫護人員能夠主動採取行動以阻止流行病。即使在 COVID-19 的威脅已經過去之後，虛擬醫療保健策略也能帶來高利潤並且得到很好的實施。

全球移動健康 (mHealth) 報告將提供對大約 40 多個市場數據表、45 多個圖表和 200 頁（大約）的訪問。

內容

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第 4 章市場動態

  • 市場影響因子
    • 驅動程序
      • 提供好處和便利
      • 提高認識
    • 阻礙因素
      • 隱私和安全風險
    • 商機
    • 影響分析

第五章行業分析

  • 波特五力分析
  • 供應鏈分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 的市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按服務分類

  • 健身與保健解決方案
  • 諮詢服務
  • 監控
  • 診斷服務
  • 治療
  • 預防

第 8 章. 按應用程序

  • 體溫監測器
  • 血糖監測儀
  • 心臟監護儀
  • 血流動力學監測儀
  • 神經系統監視器
  • 遠程病人監護設備
  • 呼吸監護儀

第 9 章，最終用戶

  • 醫療保健提供者
  • 醫療保健消費者
  • 公共和私人保險公司
  • 其他

第 10 章按地區劃分

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第 11 章競爭格局

  • 主要發展和戰略
  • 公司份額分析
  • 產品基準

第 12 章公司簡介

  • GE healthcare
    • 公司概況
    • 產品組合和描述
    • 主要亮點
    • 財務摘要
  • One Medical
  • Apple
  • OMADA Health
  • Omron Healthcare
  • LifeWatch
  • Medtronics Plc
  • Johnson & Johnson
  • Samsung Healthcare Solutions
  • AT&T
  • Philips Healthcare
  • Bayer Healthcare

第13章 DataM

簡介目錄
Product Code: DMHCIT234

Market Overview

Mobile Health Market size was valued at US$ YY million in 2021 and is estimated to reach US$ YY million by 2029, growing at a CAGR of YY% during the forecast period (2022-2029).

Mobile health (mHealth) is a broad phrase for using mobile phones and other wireless technology in medical care. The most common application of mHealth is the use of mobile devices to educate consumers about preventive healthcare services.

Market Dynamics

Growing awareness about healthcare management, increasing use of smartphones and tablets owing to the benefits and convenience, and increasing focus on personalized medicine drive the global mHealth market.

The benefits and convenience offered by mobile health (mHealth) are pushing the market growth.

The benefits and convenience offered by mobile health are fueling the global market growth. For instance, mobile health technologies help patients quickly send secure messages, schedule appointments and connect 24/7 for telemedicine visits. In particular, telemedicine is among the fastest growing ways patients use mHealth apps on their mobile devices. It also improves medication adherence by providing patients with features such as automated medication and refills reminders and educational information that enhances the probability, they'll take their medications properly. Furthermore, telehealth enables patients to use mobile devices and mobile health technology to gather, enter, or automatically collect health data and convey it to healthcare providers, allowing remote patient monitoring, a subcategory of home care. Moreover, Mhealth improves medication reconciliation precision, that in turn improves patient safety example of which is the Cureatr Meds 360 solution offers providers and other clinicians a bird's-eye view of all medications a patient has been prescribed with pick up and refill history, dosage changes, and more on an uncluttered, iPhone or Android screen display.

Privacy and security risks will restrain global mobile health (mHealth) growth.

However, with the threat of constant hacking or data discrepancy, security and privacy concerns will hamper the global market growth in the forecast period.

COVID-19 Impact Analysis

During the outburst, there was an increased focus on telemedicine and virtual care, which made it a bit convenient to fight against the pandemic with the constant risk of getting infected with the virus, significantly impacting the global market growth. For example, Harward Global Health Institute created a COVID-19 forecasting model enabling an early alert system for COVID-19 cases, hospitalizations, ICU admissions, ventilator utilization, and deaths, allowing healthcare professionals to act with a proactive attitude in squelching the pandemic. Even after the threat of COVID-19 virtual healthcare strategy is highly practiced since it offers considerable benefits.

Segment Analysis

The monitoring services segment of mobile health (mHealth) is expected to grow at the fastest CAGR during the forecast period (2022-2029).

The monitoring services are expected to dominate the global market during the forecast period (2022-2029). Owing to the advantages and benefits offered by remote monitoring using smartphones since there are over three billion smartphone users worldwide, making it the most straightforward manner to reaching out to multitudes and remote areas, with smartphone technologies, wearable sensors, and smartphone platforms, remote monitoring the health/vitals of patients have become very easy and convenient. Resulting in preventive care, well-timed diagnosis, screening of ailments, and timely treatment, which in turn has reduced and will significantly reduce the number of hospital visits, and hospitalization, reducing hospital-induced infections. Collectively, all these benefits result in improving the quality of life. Furthermore, for effective patient care and safety, constant monitoring of physiological parameters is needed, which the technology's flexibility allows through real-time basis monitoring of the parameters in non-clinical environments such as home, office, park, traveling, Etc. and ease the communication of alerts/notifications to the healthcare professional, so urgent attention can be provided remotely in case of an emergency.

Geographical Analysis

The North America region will dominate the global mobile health (mHealth).

North America is expected to dominate the global market during the forecast period (2022-2029) since most of the key players in this market, such as one medical, GE Healthcare, Apple, OMADA Health, Medtronics Plc, Johnson & Johnson, AT&T are U.S. based and with different market, strategies have a hold over a large share of the market. For instance, in February 2022, Hartford HealthCare and One Medical Announce Collaboration Focused on Seamless Coordinated Care; in September 2021, One Medical acquired Iora Health, a human-centered, value-based primary care organization with built-for-purpose technology focused on serving the Medicare senior population.

Also, in April 2021, Omada Health Launched the First Virtual Cardiometabolic Clinic, a Physician-Guided Care Program; in May 2020, Omada Health Acquired Physera, a leading musculoskeletal care company that delivers interventions digitally and via telehealth.

Competitive Landscape

The key players operating in the global mobile health (mHealth) market are One Medical, GE Healthcare, Apple, OMADA Health, Omron Healthcare, LifeWatch, Medtronics Plc, Johnson & Johnson, Samsung Healthcare Solutions, AT&T, Philips Healthcare, and Bayer Healthcare. The key players are adopting various strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the growth of Mobile health (mHealth) globally. For instance, In January 2022, OMRON Healthcare, Inc. introduced VitalSight in the United States, Hypertension Plus in the U.K., and HeartVoice in Singapore to encourage more powerful active health condition management, boost the patient-physician association, and guide behavior change that reduces or eliminates heart attack and stroke risk.

GE Healthcare

Overview:

GE Healthcare is headquartered in Chicago, Illinois, United States, founded in 2004. It is a subsidiary of American Multinational Conglomerate General Electric. It is a leading manufacturer and distributor of diagnostic imaging and radiopharmaceuticals for imaging modalities used in medical imaging procedures.

Product Portfolio:

GE Healthcare's product portfolio for mHealth has Carestation Insights LIVE Mobile Application, Centricity Universal Viewer Zero Footprint, Vscan Extend Bladder Volume App, Vscan Extend Lung Protocol App, Vscan Extend Protocol Creator App, Etc.

The global mobile health (mHealth) report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 200 (approximate) pages.

Table of Contents

Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Benefits and Convenience Offered
      • 4.1.1.2. Increased Awareness
    • 4.1.2. Restraints
      • 4.1.2.1. Privacy and Security Risks
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Service

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service Segment
    • 7.1.2. Market Attractiveness Index, By Service Segment
  • 7.2. Fitness & Wellness Solutions
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Consultation Services
  • 7.4. Monitoring
  • 7.5. Diagnostic
  • 7.6. Treatment
  • 7.7. Prevention

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
    • 8.1.2. Market Attractiveness Index, By Application Segment
  • 8.2. Body and Temperature Monitors
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Blood Glucose Monitors
  • 8.4. Cardiac Monitors
  • 8.5. Hemodynamic Monitors
  • 8.6. Neurological Monitors
  • 8.7. Remote Patient Monitoring Devices
  • 8.8. Respiratory Monitors

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
    • 9.1.2. Market Attractiveness Index, By End-User Segment
  • 9.2. Healthcare Providers
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Healthcare Consumers
  • 9.4. Public & Private Insurers
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, US$ Million, 2021-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. The U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. The U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Service
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Product Benchmarking

12. Company Profiles

  • 12.1. GE Healthcare
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. One Medical
  • 12.3. Apple
  • 12.4. OMADA Health
  • 12.5. Omron Healthcare
  • 12.6. LifeWatch
  • 12.7. Medtronics Plc
  • 12.8. Johnson & Johnson
  • 12.9. Samsung Healthcare Solutions
  • 12.10. AT&T
  • 12.11. Philips Healthcare
  • 12.12. Bayer Healthcare

LIST NOT EXHAUSTIVE

13. DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us